Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast

Eddie Myers1, Arnold D K Hill, Gabrielle Kelly

  • 1Department of Surgery, Saint Vincent's University Hospital University College Dublin, Dublin 4, Ireland.

Abstract

Insights

Transcription factors Ets-1 and Ets-2 are linked to poorer breast cancer survival. Their interaction with coactivators SRC-1 and AIB1, and coregulator NCoR, impacts recurrence and HER2 expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p160 coactivator proteins are implicated in endocrine therapy resistance.
  • Nuclear receptor coregulatory proteins may interact with nonsteroid receptors.

Purpose of the Study:

  • Investigate interactions between mitogen-activated protein kinase-activated transcription factors (Ets) and coactivators SRC-1, AIB1, and corepressor NCoR in human breast cancer.
  • Determine the prognostic significance of these interactions.

Main Methods:

  • Utilized immunohistochemistry and immunofluorescence to assess protein expression and coexpression in 134 breast tumor patients.
  • Employed Western blot, electromobility shift, and coimmunoprecipitation assays to analyze protein expression, DNA interactions, and protein-protein interactions.

Main Results:

  • Ets-1 and Ets-2 expression correlated with reduced disease-free survival (P < 0.0292, P < 0.0001).
  • NCoR served as a positive prognostic indicator (P < 0.0297).
  • Growth factors induced Ets-DNA interactions, coactivator recruitment, and HER2 upregulation, particularly with Ets-2 and SRC-1 coexpression, which strongly associated with recurrence and HER2 expression (P < 0.0001).

Conclusions:

  • Established associations between nonsteroid transcription factors (Ets) and coregulatory proteins in human breast cancer.
  • Demonstrated interactions between Ets proteins, coactivators (SRC-1, AIB1), and corepressor (NCoR).
  • Highlighted the clinical relevance of these interactions in predicting breast cancer prognosis and recurrence.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...